Five-Year Outcomes of the Danish Cardiovascular Screening (DANCAVAS) Trial

Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association

(2022) Connie W. Tsao et al.   CIRCULATION

Cost effectiveness of population screening vs. no screening for cardiovascular disease: the Danish Cardiovascular Screening trial (DANCAVAS)

(2022) Rikke Søgaard et al.   EUROPEAN HEART JOURNAL

Why and when to screen for cardiovascular disease in healthy individuals

(2021) Jes Sanddal Lindholt et al.   HEART

Baseline findings of the population‐based, randomized, multifaceted Danish cardiovascular screening trial (DANCAVAS) of men aged 65–74 years

(2019) J. S. Lindholt et al.   BRITISH JOURNAL OF SURGERY

Umbrella review and meta-analysis of antiplatelet therapy for peripheral artery disease

(2019) G. K. Ambler et al.   BRITISH JOURNAL OF SURGERY

Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly

(2018) John J. McNeil et al.   NEW ENGLAND JOURNAL OF MEDICINE

The DanCavas Pilot Study of Multifaceted Screening for Subclinical Cardiovascular Disease in Men and Women Aged 65–74 Years

(2017) T.V. Kvist et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial

(2017) Jes S Lindholt et al.   LANCET

The Danish Cardiovascular Screening Trial (DANCAVAS): study protocol for a randomized controlled trial

(2015) Axel Cosmus Pyndt Diederichsen et al.   Trials

Cost effectiveness of abdominal aortic aneurysm screening and rescreening in men in a modern context: evaluation of a hypothetical cohort using a decision analytical model

(2012) R. Sogaard et al.   BMJ-British Medical Journal

Challenges and Opportunities for Cardiovascular Disease Prevention

(2011) Manuel Franco et al.   AMERICAN JOURNAL OF MEDICINE

Generation of a Danish TTO value set for EQ-5D health states

(2009) Kim U. Wittrup-Jensen et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH